Aoxing Pharmaceutical Company, Inc.

AOXG

US03740A1060

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 07:00:00 04/06/2024 pm IST			5-day change	1st Jan Change
0.0042 ^USD	+5.00%		+5.00%	+35.48%

2017	Aoxing Pharmaceutical Company, Inc. Executive Changes	CI
2017	Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017	CI

Aoxing Pharmaceutical Company, Inc. Announces the Resignation of John O'shea as Member of the Board of Directors

October 10, 2012 at 09:00 pm IST

On October 8, 2012 John O'Shea resigned from his position as a member of the Board of Directors of Aoxing Pharmaceutical Company, Inc. Mr. O'Shea's resignation did not occur because of any disagreement with Aoxing Pharma on any matter relating to the Aoxing Pharma's operations, policies or practices.

Latest news about Aoxing Pharmaceutical Company, Inc.

Aoxing Pharmaceutical Company, Inc. Executive Changes	05/17/05	CI
Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017	16/17/16	CI
Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016	14/17/14	CI
Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016	14/16/14	CI
Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016	05/16/05	CI
Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016	16/16/16	CI
Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016	08/16/08	CI
Aoxing Pharmaceutical Company, Inc. Announces Executive Changes	01/16/01	CI
Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai	10/15/10	CI
Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center	04/15/04	CI
Aoxing Pharmaceutical Company, Inc. Announces Management Changes	02/15/02	CI
Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015	13/15/13	CI
Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt	13/15/13	CI
Aoxing Pharmaceutical Company, Inc. Announces Consolidated Earnings Results for the Year Ended June 30, 2015; Provides Earnings Guidance for the Fiscal Year 2016	13/15/13	CI
Aoxing Pharmaceutical Company, Inc. Announces Management Changes	29/14/29	CI
Aoxing Pharmaceutical Company, Inc. Announces Earnings Results for the Year Ended June 30, 2014	29/14/29	CI
Aoxing Pharmaceutical Company, Inc. Appoints Zhimin Li to its Board	07/14/07	CI
Aoxing Pharmaceutical Company, Inc. Announces Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014	15/14/15	CI
Aoxing Pharmaceutical Company, Inc. Announces Earnings Results for the Second Quarter and Six Month Periods Ended December 31, 2013	19/14/19	CI
Aoxing Pharmaceutical Company, Inc. Announces Financial Results for the First Quarter Ended September 30, 2013	15/13/15	CI
Aoxing Pharmaceutical Company, Inc. Announces Earnings Results for the Year Ended June 30, 2013	16/13/16	CI
Aoxing Pharmaceutical Company, Inc. Announces Earnings Results for the Third Quarter and Nine Month Periods Ended March 31, 2013	16/13/16	CI
Aoxing Pharmaceutical Company, Inc. Announces Earnings Results for the Second Quarter and Six Months Ended December 31, 2012	15/13/15	CI
Aoxing Pharmaceutical Company, Inc. Announces Receipt of Production License for Pholcodine	28/13/28	CI
Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2012	14/12/14	CI

Chart Aoxing Pharmaceutical Company, Inc.

Duration

Period

Chart Aoxing Pharmaceutical Company, Inc.

More charts

Company Profile

Aoxing Pharmaceutical Company, Inc. is a specialty pharmaceutical company specializing in research, development, manufacturing and distribution of a range of narcotic, pain-management and addiction treatment pharmaceutical products. The Company holds approximately 140 drug production certificates covering narcotic pain-management, prescription medicines, over-the-counter (OTC) and active pharmaceutical ingredient (API) products. Its products include prescription drugs, such as Tilidine hydrochloride, Zhongtong'an and Humifuse Euphorbia Herb Tablet, and OTC drugs, such as Shanmei Capsule, Shaoshang Tincture, Yiqi Qiangshen Granule, Xiaopiling Granule, Xiongjushangqing Tablet, Juyuansuanbijia Oral Solutions, Longdanxiegan Tablet, Fenka Tablet, Shujinhuoxue Tablet, Fuketiaojing Tablet, Qingnao Jiangya Tablet, Yuanhu Pain Management Tablet, Bushenqiangshen Tablet, Baiziyangxin Pill, Qingguo Pill, Liuweidihuang Pill, Zhibaidihuang Pill, Xiaoyao Pill and Tianwangbuxin Pill.

Sector

Pharmaceuticals

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
AOXING PHARMACEUTICAL COMPANY, INC.	+35.48%	14.33L
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.64%	4.23TCr
OTSUKA HOLDINGS CO., LTD.	+21.25%	2.25TCr
SANDOZ GROUP AG	+18.48%	1.52TCr
ZYDUS LIFESCIENCES LIMITED	+53.19%	1.26TCr
THE MEDICINES COMPANY	-0.05%	678.76Cr
ONO PHARMACEUTICAL CO., LTD.	-11.11%	670.62Cr
STADA ARZNEIMITTEL	-8.87%	572.55Cr
ASPEN PHARMACARE HOLDINGS LIMITED	+14.27%	546.57Cr
GEDEON RICHTER	+6.91%	477.68Cr

Generic Pharmaceuticals